Pulling SEC filings + quote and writing the call…

NeuroPace Inc
Next earnings Aug 10, 2026 · consensus $-0.21 EPS, $23.1M rev
Last earnings +0.8% on 2026-05-12
Revenue grew 25.1% YoY; but unprofitable (net margin -21.5%).
NeuroPace Inc shows $100.0M in FY2025 revenue (+25.1% YoY), a -21.5% net margin, and -112.8% ROE.
Sources: SEC EDGAR (CIK 0001528287, latest 10-Q filed 2026-05-12) · EODHD · as of 6/26/2026, 7:40:14 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $45.2M | $45.5M | $65.4M | $79.9M | $100.0M |
| Gross profit | $33.4M | $32.5M | $48.1M | $59.1M | $77.2M |
| Operating income | -$23.7M | -$40.8M | -$27.2M | -$21.7M | -$16.3M |
| Net income | -$36.1M | -$47.1M | -$33.0M | -$27.1M | -$21.5M |
| Diluted EPS | -$2.17 | -$1.91 | -$1.27 | -$0.93 | -$0.66 |
| Net margin | -79.9% | -103.4% | -50.4% | -34.0% | -21.5% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1049 tracked peers · median
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
| 2026-06-24 | Morrell Martha CHIEF MEDICAL OFFICER | Tax | 335.00 @ $16.22 | $5.43K |
| 2026-06-19 | Geiger Uri Director | Award | 789.00 @ $15.63 | $12.3K |
| 2026-06-19 | Fischer Frank M Director | Award | 1.47K @ $15.63 | $22.9K |
| 2026-06-19 | Kumar Rakhi Director | Award | 989.00 @ $15.63 | $15.5K |
| 2026-06-05 | Huennekens R Scott Director | Award | 2.89K | |
| 2026-06-05 | Fischer Frank M Director | Award | 2.89K | |
| 2026-06-05 | Geiger Uri Director | Award | 2.89K | |
| 2026-06-05 | Kumar Rakhi Director | Award | 2.89K |
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.